The antitumorigenic effect of AAV-mediated miR-26 replacement strategy was previously reported in a c-MYC transgenic model of liver cancer, resulting in inhibition of cancer cell proliferation and tumor progression [26]. The gene discussed is MYC; the disease is neoplasm.